Grown Rogue International (GRUSF) Cash from Operations Growth (3y) (2016 - 2023)
Grown Rogue International (GRUSF) Cash from Operations Growth (3y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 34.90% |
| 3 | Zoetis | 32.70 Bn | 30.76 Bn | 1.62 Bn | -9.94% |
| 4 | Takeda Pharmaceutical | 27.73 Bn | 23.67 Bn | 4.39 Bn | -10.80% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 7.32% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.18 Bn | 18.37 Bn | 1.16 Bn | -26.33% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 46.81% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 27.85% |
| 10 | Grown Rogue International | 99.99 Mn | 86.29 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 125.26% |
| Jul 31, 2023 | 158.92% |
| Apr 30, 2023 | 129.53% |
| Jan 31, 2023 | 62.21% |
| Jan 31, 2022 | 26.57% |
| Oct 31, 2021 | 20,976.42% |
| Jul 31, 2021 | -43.15% |
| Apr 30, 2021 | 39.14% |
| Jan 31, 2021 | 28.74% |
| Aug 31, 2018 | 27.41% |
| May 31, 2018 | 66.06% |
| May 31, 2017 | -33.69% |
| Nov 30, 2016 | -56.07% |
| Aug 31, 2016 | 2.05% |